In a groundbreaking study, scientists at the Chinese Academy of Sciences in Shanghai and Fudan University have created the first laboratory-made sinoatrial node, the heart's natural pacemaker, using human stem cells. Published on May 15 in Stem Cell Research, this innovative organoid can autonomously beat and may significantly enhance research into cardiac diseases and biological pacemaker therapies. The sinoatrial node, located in the heart's right atrial chamber, is essential for generating electrical signals that regulate heart contractions. Malfunctions can lead to dangerously slow or halted heartbeats. The researchers engineered the organoid by mimicking embryonic development signals and connecting it to an artificial cardiac plexus, allowing it to simulate nervous system control over heart rhythm. Remarkably, the organoid produced stable spontaneous beating and effectively transmitted electrical signals to atrial-like tissue, replicating the natural pacemaking process. This advancement may support future strategies involving cell or organoid transplants as alternatives to traditional electronic pacemakers, which face challenges such as infection risks and limited adaptability.